232 related articles for article (PubMed ID: 31793033)
1. Abaloparatide at the Same Dose Has the Same Effects on Bone as PTH (1-34) in Mice.
Le Henaff C; Ricarte F; Finnie B; He Z; Johnson J; Warshaw J; Kolupaeva V; Partridge NC
J Bone Miner Res; 2020 Apr; 35(4):714-724. PubMed ID: 31793033
[TBL] [Abstract][Full Text] [Related]
2. Abaloparatide Has the Same Catabolic Effects on Bones of Mice When Infused as PTH (1-34).
Le Henaff C; Finnie B; Pacheco M; He Z; Johnson J; Partridge NC
JBMR Plus; 2023 Feb; 7(2):e10710. PubMed ID: 36751417
[TBL] [Abstract][Full Text] [Related]
3. Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption.
Chandler H; Lanske B; Varela A; Guillot M; Boyer M; Brown J; Pierce A; Ominsky M; Mitlak B; Baron R; Kostenuik P; Hattersley G
Bone; 2019 Mar; 120():148-155. PubMed ID: 30343166
[TBL] [Abstract][Full Text] [Related]
4. One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption.
Varela A; Chouinard L; Lesage E; Smith SY; Hattersley G
J Bone Miner Res; 2017 Jan; 32(1):24-33. PubMed ID: 27748532
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of parathyroid hormone, parathyroid hormone-related protein, and abaloparatide on collagen 1 expression by mouse cementoblasts and mouse tooth root density.
Hsu C; He Z; Le Henaff C; Partridge NC
Am J Orthod Dentofacial Orthop; 2023 Mar; 163(3):378-388.e1. PubMed ID: 36543659
[TBL] [Abstract][Full Text] [Related]
6. Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β-arrestin recruitment than teriparatide.
Sahbani K; Cardozo CP; Bauman WA; Tawfeek HA
Physiol Rep; 2019 Oct; 7(19):e14225. PubMed ID: 31565870
[TBL] [Abstract][Full Text] [Related]
7. Abaloparatide, the second generation osteoanabolic drug: Molecular mechanisms underlying its advantages over the first-in-class teriparatide.
Bhattacharyya S; Pal S; Chattopadhyay N
Biochem Pharmacol; 2019 Aug; 166():185-191. PubMed ID: 31136739
[TBL] [Abstract][Full Text] [Related]
8. Abaloparatide is more potent than teriparatide in restoring bone mass and strength in type 1 diabetic male mice.
Marino S; Ozgurel SU; McAndrews K; Cregor M; Villaseñor A; Mamani-Huanca M; Barbas C; Gortazar A; Sato AY; Bellido T
Bone; 2024 Apr; 181():117042. PubMed ID: 38360197
[TBL] [Abstract][Full Text] [Related]
9. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
[TBL] [Abstract][Full Text] [Related]
10. A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study.
Horwitz MJ; Augustine M; Khan L; Martin E; Oakley CC; Carneiro RM; Tedesco MB; Laslavic A; Sereika SM; Bisello A; Garcia-Ocaña A; Gundberg CM; Cauley JA; Stewart AF
J Bone Miner Res; 2013 Nov; 28(11):2266-76. PubMed ID: 23661240
[TBL] [Abstract][Full Text] [Related]
11. Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia.
Chandler H; Brooks DJ; Hattersley G; Bouxsein ML; Lanske B
Osteoporos Int; 2019 Aug; 30(8):1607-1616. PubMed ID: 31053927
[TBL] [Abstract][Full Text] [Related]
12. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
14. Abaloparatide improves cortical geometry and trabecular microarchitecture and increases vertebral and femoral neck strength in a rat model of male osteoporosis.
Besschetnova T; Brooks DJ; Hu D; Nagano K; Nustad J; Ominsky M; Mitlak B; Hattersley G; Bouxsein ML; Baron R; Lanske B
Bone; 2019 Jul; 124():148-157. PubMed ID: 31051317
[TBL] [Abstract][Full Text] [Related]
15. Teriparatide and Abaloparatide Have a Similar Effect on Bone in Mice.
Brent MB; Stoltenborg FE; Brüel A; Thomsen JS
Front Endocrinol (Lausanne); 2021; 12():628994. PubMed ID: 33953694
[TBL] [Abstract][Full Text] [Related]
16. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.
Doyle N; Varela A; Haile S; Guldberg R; Kostenuik PJ; Ominsky MS; Smith SY; Hattersley G
Osteoporos Int; 2018 Mar; 29(3):685-697. PubMed ID: 29260289
[TBL] [Abstract][Full Text] [Related]
17. Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice.
Arlt H; Mullarkey T; Hu D; Baron R; Ominsky MS; Mitlak B; Lanske B; Besschetnova T
Bone Rep; 2020 Dec; 13():100291. PubMed ID: 32637467
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice.
Xie Y; Yi L; Weng T; Huang J; Luo F; Jiang W; Xian CJ; Du X; Chen L
Int J Biol Sci; 2016; 12(8):990-9. PubMed ID: 27489502
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General Similar.
Brent MB; Thomsen JS; Brüel A
Front Endocrinol (Lausanne); 2020; 11():588773. PubMed ID: 33162940
[TBL] [Abstract][Full Text] [Related]
20. Differential transcriptional effects of PTH and estrogen during anabolic bone formation.
von Stechow D; Zurakowski D; Pettit AR; Müller R; Gronowicz G; Chorev M; Otu H; Libermann T; Alexander JM
J Cell Biochem; 2004 Oct; 93(3):476-90. PubMed ID: 15372627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
